Riskpilot← Back to searchSign inGet full accessA3P Lab AB
ABActiveOrg 5591630255Vallongatan 1Engineering activities and related technical consultancy · NACE 7112Est. 20187 employees
Revenue 2024
SEK 15,6M
+51% vs 2023
EBITDA margin
-15.4%
+69% vs 2023
Equity ratio
72.6%
Financial strength
Net profit 2024
SEK 8K
-91% vs 2023
| Revenue | SEK 15,6M | +51% |
| EBITDA | SEK -2,4M | +69% |
| Net profit | SEK 8K | -91% |
| Total assets | SEK 19,2M | -11% |
| Equity | SEK 13,9M | +0% |
| Employees | 7 | — |
Legal name
A3P Lab AB
Org number
5591630255
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
20 juni 2018
Share capital
SEK 50 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva försäljning av varor, tjänster och konsultverksamhet inom molekylärbiologi, bioteknik och biomedicin samt därmed förenlig verksamhet samt bedriva kapitalförvaltning.
Address
Vallongatan 1
Email
info@a3p.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 106 523 | 21 611 | 19 989 | 10 315 | 15 610 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 26 166 | −19 760 | −6 555 | −7 885 | −2 410 |
| Depreciation & amort. | −4 700 | −459 | −1 160 | −1 080 | −1 159 |
| EBIT | 21 466 | −20 219 | −7 715 | −8 965 | −3 569 |
| Net financials | −5 | −125 | −36 | 59 | 78 |
| Profit before tax | 16 161 | −10 696 | 350 | 94 | 8 |
| Tax | −3 471 | −0 | −0 | −0 | −0 |
| Net profit | 12 690 | −10 696 | 350 | 94 | 8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 94 131 | 19 534 | 25 032 | 21 433 | 19 151 |
| Equity | 16 157 | 5 461 | 13 811 | 13 905 | 13 913 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 71 225 | 13 973 | 11 221 | 7 528 | 5 237 |
| Total debt | 71 225 | 13 973 | 11 221 | 7 528 | 5 237 |
EBITDA margin
-15.4%
This company
15.8%
Market median
-197% vs market
20202024
Equity ratio
72.6%
This company
38.2%
Market median
+90% vs market
20202024
Return on equity
0.1%
This company
18.4%
Market median
-99% vs market
20202024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20202024
Asset turnover
0.82×
This company
1.12×
Market median
+27% vs market
20202024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JE Chief Auditor | Chief Auditor | 2021 |
DO Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
KD Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
MB Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
KJ Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
A3P Biomedical AB (publ)
A3P Lab AB Board members of A3P Lab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl David Rosén | Chief Executive Officer | 0 companies |
| Malin Birgitta Gidlund | Chief Executive Officer | 0 companies |
| Karl Johan Andersson | Chief Executive Officer | 0 companies |
| Johan Erik Niclas Bergenmo | Chief Auditor | 0 companies |
| Daniel Ola Steinberg | Chief Executive Officer | 0 companies |
| Jan Martin Steinberg | Deputy Board Member | 0 companies |
| Elsa Marianne Waplan | Deputy Board Member | 0 companies |